Previous 10 | Next 10 |
home / stock / tlt / tlt articles
It’s a mixed Friday on Wall Street, with tech investors cheering stellar earnings from Amazon.com, Inc. (NASDAQ:AMZN) and an in-line personal...
Wall Street experienced a significant downturn Thursday as volatility surged, triggered by a shift in risk sentiment following a combination of mix...
It’s a day of risk aversion on Wall Street as investors are shedding both stocks and bonds in favor of cash while digesting the latest corpor...
It’s a risk-on start to the week, with investors favoring riskier assets, buoyed by a significant drop in Treasury yields and a weakening U.S...
Risk sentiment remains extremely fragile as the week draws to a close, with the threat of an escalation in the Middle East intensifying. All major ...
Thursday saw the U.S. stock market displaying mixed performance as 10-year Treasury yields approached the 5% threshold, only to recover in response...
Wall Street tumbled during midday trading, with all major stock indices in the red, and only the energy sector showing gains for the session, while...
Risk sentiment held steady on Tuesday as corporations continued to report better-than-expected earnings. Johnson & Johnson (NYSE:JNJ), Bank of ...
Wall Street started the week on a positive note, as all major U.S. indices and every sector within the S&P 500 showed gains during the morning ...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...